54 related articles for article (PubMed ID: 23007409)
1. Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.
Gray SG; Baird AM; O'Kelly F; Nikolaidis G; Almgren M; Meunier A; Dockry E; Hollywood D; Ekström TJ; Perry AS; O'Byrne KJ
Int J Mol Med; 2012 Dec; 30(6):1505-11. PubMed ID: 23007409
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
Alcazar O; Achberger S; Aldrich W; Hu Z; Negrotto S; Saunthararajah Y; Triozzi P
Int J Cancer; 2012 Jul; 131(1):18-29. PubMed ID: 21796622
[TBL] [Abstract][Full Text] [Related]
3. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
4. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
Cai Y; Geutjes EJ; de Lint K; Roepman P; Bruurs L; Yu LR; Wang W; van Blijswijk J; Mohammad H; de Rink I; Bernards R; Baylin SB
Oncogene; 2014 Apr; 33(17):2157-68. PubMed ID: 23708667
[TBL] [Abstract][Full Text] [Related]
5. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.
Xiang N; Zhao R; Song G; Zhong W
Carcinogenesis; 2008 Nov; 29(11):2175-81. PubMed ID: 18676679
[TBL] [Abstract][Full Text] [Related]
6. Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method.
Liu Z; Liu S; Xie Z; Blum W; Perrotti D; Paschka P; Klisovic R; Byrd J; Chan KK; Marcucci G
Nucleic Acids Res; 2007; 35(5):e31. PubMed ID: 17264127
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of demethylating agents in hematology.
Navada SC; Steinmann J; Lübbert M; Silverman LR
J Clin Invest; 2014 Jan; 124(1):40-6. PubMed ID: 24382388
[TBL] [Abstract][Full Text] [Related]
8. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis.
Dunn J; Qiu H; Kim S; Jjingo D; Hoffman R; Kim CW; Jang I; Son DJ; Kim D; Pan C; Fan Y; Jordan IK; Jo H
J Clin Invest; 2014 Jul; 124(7):3187-99. PubMed ID: 24865430
[TBL] [Abstract][Full Text] [Related]
9. A pharmacodynamic assay to monitor treatment with the hypomethylating cytosine analogs, decitabine and azacitidine.
Jacobberger JW; Woost PG
Methods Cell Biol; 2024; 186():131-150. PubMed ID: 38705597
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer.
Weng RR; Lu HH; Lin CT; Fan CC; Lin RS; Huang TC; Lin SY; Huang YJ; Juan YH; Wu YC; Hung ZC; Liu C; Lin XH; Hsieh WC; Chiu TY; Liao JC; Chiu YL; Chen SY; Yu CJ; Tsai HC
Nat Commun; 2021 Apr; 12(1):2163. PubMed ID: 33846331
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 promotes intestinal tumor growth via DNA methylation.
Xia D; Wang D; Kim SH; Katoh H; DuBois RN
Nat Med; 2012 Jan; 18(2):224-6. PubMed ID: 22270723
[TBL] [Abstract][Full Text] [Related]
12. Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.
Camilo V; Pacheco MB; Moreira-Silva F; Outeiro-Pinho G; Gaspar VM; Mano JF; Marques CJ; Henrique R; Jerónimo C
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892208
[TBL] [Abstract][Full Text] [Related]
13. Effect of Zebularine on Apoptotic Pathways in Hepatocellular Carcinoma Cell Lines.
Sanaei M; Kavoosi F
Int J Prev Med; 2023; 14():63. PubMed ID: 37351028
[TBL] [Abstract][Full Text] [Related]
14. Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.
Jan CI; Huang SW; Canoll P; Bruce JN; Lin YC; Pan CM; Lu HM; Chiu SC; Cho DY
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663641
[TBL] [Abstract][Full Text] [Related]
15. The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems.
Yang C; He B; Dai W; Zhang H; Zheng Y; Wang X; Zhang Q
Acta Pharm Sin B; 2021 Apr; 11(4):961-977. PubMed ID: 33996409
[TBL] [Abstract][Full Text] [Related]
16. Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma.
Gray SG
BMC Pulm Med; 2021 May; 21(1):148. PubMed ID: 33952230
[TBL] [Abstract][Full Text] [Related]
17. Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.
Dodge MJ; MacNeil KM; Tessier TM; Weinberg JB; Mymryk JS
Antiviral Res; 2021 Apr; 188():105034. PubMed ID: 33577808
[TBL] [Abstract][Full Text] [Related]
18. Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).
Crabb SJ; Danson S; Catto JWF; Hussain S; Chan D; Dunkley D; Downs N; Marwood E; Day L; Saunders G; Light M; Whitehead A; Ellis D; Sarwar N; Enting D; Birtle A; Johnson B; Huddart R; Griffiths G
Clin Cancer Res; 2021 Apr; 27(7):1882-1892. PubMed ID: 33472913
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives.
Gray SG; Mutti L
Transl Lung Cancer Res; 2020 Feb; 9(Suppl 1):S100-S119. PubMed ID: 32206576
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.
Xu S; Zhan M; Jiang C; He M; Yang L; Shen H; Huang S; Huang X; Lin R; Shi Y; Liu Q; Chen W; Mohan M; Wang J
Nat Commun; 2019 Dec; 10(1):5492. PubMed ID: 31792210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
